Green M, Williams VS, Witherspoon D, Dixon-Roman E, Windle M. Religiosity, spirituality, and African American college student alcohol consumption. Alcohol Clin Exp Res. 2002 Jun;26(5):73A.
Ortiz M, Neighbors DM. Collecting evidence of equivalence: implications for economic analyses. Presented at the 2002 ISPOR 7th Annual International Meeting; May 19, 2002. Arlington, VA.
Oh JS, Kucab JE, Bushel PR, Martin K, Bennett L, Collins J, DiAugustine RP, Barrett JC, Afshari CA, Dunn SE. Insulin-like growth factor-1 inscribes a gene expression profile for angiogenic factors and cancer progression in breast epithelial cells. Neoplasia. 2002 May 1;4(3):204-17.
Irish WD, Neighbors DM, Grogg A, Lopez R, Girts T, Degen K. Performing epidemiological studies in schizophrenia: a propensity score model to predict selection of atypical antipsychotic. Poster presented at the 2002 ISPOR 7th Annual International Meeting; May 2002. Arlington, VA. [abstract] Value Health. 2002 May; 5(1):216.
Fehnel SE, McLeod LD. Psychometrics for the non-psychometrician. Presented at the Seventh Annual International Meeting of the International Society for Pharmacoeconomics and Outcomes Research; May 2002.
Copley-Merriman K, Pawel J, Shepard F, Kimmel K, Gulyas S, Eckert S. Randomized phase 2 study of the oral histone deacetylase inhibitor ci-994 plus gemcitabine vs. placebo plus gemcitabine in second-line nsclc: health-related quality of life results. Poster presented at the American Society of Clinical Oncology; May 2002. Orlando, FL.
Lewis B, Silberman C, Heyes AE. Side effects of chemotherapy among patients with ovarian cancer. Presented at the International Society for Pharmacoeconomics and Outcomes Research 7th Annual International Meeting; May 2002. Washington, DC.
Hauber BHIV, Earnshaw SR, Spencer MD, Candrilli SD. Estimating the incidence and duration of exacerbations in chronic obstructive pulmonary disease. Poster presented at the 98th Annual Conference of the American Thoracic Society; May 2002.
Neighbors D, Irish WD, Lopez R, Degen K, Swann A, Grogg A. Inpatient medication utilization and costs of risperidone, olanzapine, and quetiapine: a retrospective chart abstraction study. Poster presented at the 2002 ISPOR 7th Annual International Meeting; May 19, 2002. Arlington, VA. [abstract] Value Health. 2002 May; 5(3):234.
Spencer MD, Hauber BHIV, Earnshaw SR, Candrilli SD. Estimating lung function decline based on ats staging classifications, and the effect of tobacco smoking in copd patients. Poster presented at the American Thoracic Society 98th International Conference; May 2002.
Moore LL, Bradlee ML, Singer MR, Rothman KJ, Milunsky A. Chromosomal anomalies among the offspring of women with gestational diabetes. Am J Epidemiol. 2002 Apr 15;155(8):719-24.
Anthony MS. Soy protein versus isoflavones in the prevention of cardiovascular disease. Presented at the Food as Drug Meeting; April 11, 2002. Turku, Finland.
Smith VK, Poulos C. Transparency and takings: an application of the regression discontinuity method. Poster presented at the National Bureau of Economic Research Environmental Working Group; April 2002.
Dennison CR, Leidy NK, Silberman C, Heyes AE. Interpretation of quality of life data from a clinician's point of view: getting to the clinically meaningful change. Presented at the Mayo Clinic Meeting: Assessing Clinical Significance for Quality of Live Measures in Oncology Research; April 2002. Rochester, MN.
Mikkola TS, Anthony MS, Clarkson TB, St. Clair RW. Serum cholesterol efflux potential in postmenopausal monkeys treated with tibolone or conjugated estrogens. Metabolism. 2002 Apr;51(4):523-30.
Erickson SR, Munzenberger PJ, Plante M, Kirking DM, Hurwitz M, Vanuya R. Influence of sociodemographics on the health-related quality of life of pediatric patients with asthma. J Asthma. 2002 Apr 1;39(2):107-17.
Rieux C, Carney R, Lupi D, Dkhissi-Benyahya O, Jansen K, Chounlamountri N, Foster RG, Cooper HM. Analysis of immunohistochemical label of Fos protein in the suprachiasmatic nucleus: comparison of different methods of quantification. J Biol Rhythms. 2002 Apr;17(2):121-36. doi: 10.1177/074873002129002410
Leidy NK, Jonas D, Silberman C, Margolis MK, Heyes AE. What does it all mean? Using health-related quality of life data to interpret treatment outcomes. Presented at the Mayo Clinic Meeting: Assessing Clinical Significance for Quality of Live Measures in Oncology Research; April 2002. Rochester, MN.
Carney R, Dardis C, Cullen WK, Felipo V, Anwyl R, Rowan MJ. Early spatial memory deficit induced by 2,5-hexanedione in the rat. Toxicol Lett. 2002 Mar 10;128(1-3):107-15. doi: 10.1016/s0378-4274(01)00538-0
Niaura R, Shadel WG, Britt DM, Abrams DB. Response to social stress, urge to smoke, and smoking cessation. Addict Behav. 2002 Mar 1;27(2):241-50.
Shah S, Sesti AM, Copley-Merriman K, Clark M. Summary of quality of life labeling components in the package inserts. Poster presented at the DIA-QOL Meeting; March 2002.
Frost L, Johnsen SP, Pedersen L, Husted S, Engholm G, Sorensen HT, Rothman KJ. Seasonal variation in hospital discharge diagnosis of atrial fibrillation: a population-based study. Epidemiology. 2002 Mar;13(2):211-5.
Cella D, Eton DT, Faircloth DL, Bonomi P, Heyes AE, Silberman C, Wolf MK, Johnson DH. What is a clinically meaningful change on the Functional Assessment of Cancer Therapy - Lung (FACT-L) questionnaire? Results from Eastern Cooperative Group (ECOG) Study 5592. J Clin Epidemiol. 2002 Mar;55(3):285-95.
McLeod LD, Fehnel SE, Brandman J, Symonds T. Minimal clinically important differences on the acne-specific quality of life questionnaire (Acne-QoL). Presented at the Drug Information Association's 9th Annual Symposium for Quality of Life Evaluation; March 2002.
Kaplan JR, Manuck SB, Anthony MS, Clarkson TB. Premenopausal social status and hormone exposure predict postmenopausal atherosclerosis in female monkeys. Obstet Gynecol. 2002 Mar;99(3):381-8.
Anthony MS, Clarkson TB. Does extent of pretreatment atherosclerosis influence the effects of conjugated equine estrogens on atherosclerosis progression? Presented at the 51st Annual Scientific Session of the American College of Cardiology; March 17, 2002. Atlanta, GA. [abstract] J Am Coll Cardiol. 2002 Mar; 39:248A.
Cid Ruzafa J, Arana A, Rueda de Castro AM, Warner BA, Kumar V, O'Sullivan D. Effective prevention of clozaril granulocyte toxicity. Presented at the XII World Congress of Psychiatry; March 2002.
Cronin MT, Dearden JC, Duffy JC, Edwards R, Manga N, Worth AP, Worgan AD. The importance of hydrophobicity and electrophilicity descriptors in mechanistically-based QSARs for toxicological endpoints. SAR QSAR Environ Res. 2002 Mar;13(1):167-76.
Hollis KA, Duffer A. The use of panels as an effective means of collecting patient-reported outcomes. Presented at the Drug Information Association's 9th Annual Symposium for Quality of Life Evaluation; March 2002.
Flavell DM, Jamshidi Y, Hawe E, Pineda Torra I, Taskinen MR, Frick MH, Nieminen MS, Kesäniemi YA, Pasternack A, Staels B, Miller G, Humphries SE, Talmud PJ, Syvänne M. Peroxisome proliferator-activated receptor alpha gene variants influence progression of coronary atherosclerosis and risk of coronary artery disease. Circulation. 2002 Feb 25;105(12):1440-5.
Smith VK, Poulos C, Kim H. Treating open space as an urban amenity. Resour Energy Econ. 2002 Feb 15;24(1-2):107-29.
Allen RM, Granger AL, Dykstra LA. Dextromethorphan potentiates the antinociceptive effects of morphine and the delta-opioid agonist SNC80 in squirrel monkeys. J Pharmacol Exp Ther. 2002 Feb 1;300(2):435-41.
Blair RM, Cline JM, Anthony MS, Clarkson TB. Use of the progestin challenge test in nonhuman primates (Macaca fascicularis). Fertil Steril. 2002 Feb;77(2):387-91.
Menter A, Gottlieb A, Griffiths C, Mordin MM. Health-related quality of life impact of weekly intravenous or intramuscular alefacept in patients with psoriasis: results from two randomized, placebo-controlled phase III trials. Poster presented at the Annual Meeting of the American Academy of Dermatology; February 2002.
Schildkraut JM, Calingaert B, Marchbanks PA, Moorman PG, Rodriguez GC. The impact of progestin and estrogen potency in oral contraceptives on ovarian cancer risk. J Natl Cancer Inst. 2002 Jan 2;94(1):32-8.
Bell T, Candrilli S, Irish W, Morris E, Cairo MS. Medical resource use and costs associated with renal complications among patients with hematologic malignancies. Blood. 2002 Jan 1;100(11):221A.
Irish WD, Neighbors D, Ortiz M. Evaluating therapeutic equivalence using meta analysis: implications for economic analysis. Poster presented at the Symposium on Meta Analysis of Medical Data sponsored by Mathematical Sciences Research Institute; 2002. Berkeley, CA.
Watts (Wideman) K, Quiroz R, McAvinchey G. Translation of survey research documents and related activities. Poster presented at the 15th Annual Carolina Association of Translators and Interpreters (CATI); 2002. Raleigh, NC.
Longo CJ, Raskin J, Gilsenan AW, Corey-Lisle P, Sherrill EH, Hopkins JS. Prevalence of treatment-resistant depression in Saskatchewan—limitations of a claims based analysis. Poster presented at the XXIII CINP Congress; 2002.
Loughlin JE, Cole JA, Rothman KJ, Johnson ES. Prevalence of serious eosinophilia and incidence of Churg-Strauss syndrome in a cohort of asthma patients. Ann Allergy Asthma Immunol. 2002 Jan 1;88(3):319-25.
Poulos C. RFF and Lave and Seskin's air pollution and human health: Rappateur's notes on sessions in honor of resources for the future's 50th Anniversary. In: RFF at Fifty: essays Reflecting on RFF's Impact in Environmental Economics. RFF; 2002.
Djousse L, Rothman KJ, Cupples LA, Levy D, Ellison RC. Serum albumin and risk of myocardial infarction and all-cause mortality in the Framingham Offspring Study. Circulation. 2002 Jan 1;106(23):2919-24.
Odom DM, Stivers J. The effects of September 11th on unit nonresponse in the national survey on drug use and health. Poster presented at the American Association for Public Opinion Research; 2002.
Ward A, Caro JJ, Green T, Huybrechts K, Arana A, Wait S, Eleftheriou A. An international survey of patients with thalassemia major and their views about sustaining life-long desferrioxamine use. BMC Clin Pharmacol. 2002;2(3).
Talmud PJ, Hawe E, Miller GJ, Humphries SE. Nonfasting apolipoprotein B and triglyceride levels as a useful predictor of coronary heart disease risk in middle-aged UK men. Arterioscler Thromb Vasc Biol. 2002;22(11):1918-23.
Talmud PJ, Hawe E, Martin S, Olivier M, Miller GJ, Rubin EM, Pennacchio LA, Humphries SE. Relative contribution of variation within the APOC3/A4/A5 gene cluster in determining plasma triglycerides. Hum Mol Genet. 2002;11(24):3039-46.
Talmud PJ, Hawe E, Robertson K, Miller GJ, Miller NE, Humphries SE. Genetic and environmental determinants of plasma high density lipoprotein cholesterol and apolipoprotein AI concentrations in healthy middle-aged men. Ann Hum Genet. 2002;66(Pt 2):111-24.
Talmud PJ, Hawe E, Miller GJ. Analysis of gene-environment interaction in coronary artery disease: lipoprotein lipase and smoking as examples. J Cardiovasc Med. 2002;3(1):6-9 Revie.
Rothman KJ, Ray W. Should cases with a 'known' cause of their disease be excluded from study? (Commentary). Pharmacoepidemiol Drug Saf. 2002 Jan 1;11(1):11-4.
Rothman KJ, Michels KB. When is it appropriate to use a placebo arm in a trial? In: Guess HA, Kleinman A, Kusek JW, Engel LW, editors. The science of the placebo: toward an interdisciplinary research agenda. London: United Kingdom. BMJ Books; 2002.